Eyes on New Product Development.

Novack, Gary D

Novack, Gary D.

Novack GD; PharmaLogic Development, Inc., San Rafael, California.

J Ocul Pharmacol Ther ; 36(4): 199-200, 2020 05.

Article in English | MEDLINE | ID: covidwho-9612

Subject(s)

Dry Eye Syndromes/drug therapy; Eye Diseases/drug therapy; Retinal Diseases/drug therapy; Administration, Ophthalmic; Biological Products/therapeutic use; COVID-19/complications; COVID-19/diagnosis; COVID-19/epidemiology; Cell- and Tissue-Based Therapy/methods; Clinical Trials as Topic; Drug Approval/legislation & jurisprudence; Drug Delivery Systems; Drug Design; Genetic Therapy/methods; Humans; SARS-CoV-2/isolation & purification; Safety

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Retinal Diseases / Dry Eye Syndromes / Eye Diseases Type of study: Diagnostic study / Observational study / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: J Ocul Pharmacol Ther Journal subject: Pharmacology / Ophthalmology / Therapeutics Year: 2020 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google